Outside the Lab

The ICCR works with pathologists and groups worldwide to develop standardized guidelines for the diagnosis and reporting of various cancer types

An advanced system can identify pathogens and detect broad-ranging resistance, allowing pathologists to select the most appropriate drugs with accuracy and speed

As deep learning moves into the pathology sphere, the way we do our jobs will change – but we have yet to determine exactly how

How combining their efforts with those of the pharmaceutical industry can help pathologists make a business case for AI

When bacteria become resistant to the last line of defense, rapid detection and treatment is more important than ever. A new assay can help with treatment selection for carbapenem-resistant infections

Can you diagnose this 29-year-old’s painful subungual tumor?

What makes pathology and laboratory medicine unique? Everyone, from trainee to department chair, receives respect

Sitting Down With Oliver Fiehn, Director of NIH West Coast Metabolomics Center

For better diagnosis and monitoring of Alzheimer’s disease, as well as drug R&D, we need to move toward widespread use of MRI biomarker imaging, even if blood screening tests become a reality

Join us in celebrating the 100 most influential professionals in the field, nominated by you and selected by a panel of pathologist judges